Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not only that, but it is likely that the people doing the peer review have a strong vested interest in delaying the Anavex paper as long as possible since their research and funding may be impacted by a paradigm shift.
As I understand it, it only takes one of the reviewers to slow down the process.
Rather, as German physicist Max Planck somewhat cynically declared, science advances one funeral at a time. Planck noted “a new scientific truth does not triumph by convincing its opponents and making them see the light, but rather because its opponents die, and a new generation grows up that is familiar with it.”
Some of the 2023 SEC enforcement actions. Cabal, maybe, maybe not. Bad actors certainly.
The SEC charged broker-dealer Citadel Securities LLC with violating a provision of Regulation SHO that requires broker-dealers to mark sale orders as long, short, or short exempt. Regulators routinely use these records to police prohibited short selling activity. According to the SEC’s order, Citadel Securities incorrectly marked an estimated millions of orders for a five-year period, inaccurately denoting certain short sales as long sales and vice versa, and provided the inaccurate data to regulators, including the SEC. Citadel paid a $7 million civil penalty to resolve the charges and consented to a set of undertakings, including a written certification that the coding error had been remediated and a review of the firm’s computer programming and coding logic involved in processing relevant transactions
Market Abuse
In fiscal year 2023, the SEC brought enforcement cases addressing a variety of abusive trading practices, such as insider trading, front-running, and market manipulation. For example, the Commission charged:
Eight social media influencers for allegedly using social media to manipulate exchange-traded stocks in a $100 million securities fraud scheme;
Two financial services industry professionals for allegedly perpetrating a multi-year front-running scheme that generated at least $47 million in illegal trading profits
n the Division’s recommendations, the Commission filed settled charges imposing robust financial remedies against major companies in actions that addressed a wide range of securities law violations.
For example:
Twenty-five advisory firms, broker-dealers, and/or credit rating agencies, including Wells Fargo, HSBC, and Scotia Capital, agreed to pay combined civil penalties totaling more than $400 million to settle charges that they violated the recordkeeping requirements of the federal securities laws;
Now if you just learn how to spell it.
Fault for the lawsuit is not the issue. The strength of the lawsuit is. And so far it looks to be a nuance rather than a serious threat.
20,000,000 shares short is not a conspiracy. The short value of $100,000,000 is not a conspiracy.
If you think that there are not efforts being made to protect that amount of money then I suggest you are being willfully blind.
According to the FDA there is only one surrogate biomarker for AD and that is plaque reduction. There are no qualified biomarkers for AD according to the most recent list I could find on the FDA web site.
The FDA has indicated that it is willing to consider other biomarkers in NDA submissions.
If I have this right, plaque reduction wasn't considered a valid surrogate biomarker until the mab NDAs were submitted.
There are a number of biomarkers that are used in diagnosing AD. What the FDA has to say about that won't be known until they are put through the qualification process or used in an NDA submission.
You are right. It is a remote possibility.
It is my understanding that in general MM's don't carry large inventories of shares. Some of the investment/brokerage houses may build an inventory but that is generally not on the MM side of the house.
I'll pose that as a question to the folks on the board that have industry experience.
So if the shares went from shareholders to shareholders... I'm confused.
So what happened on the day when there was 117 million share volume?
We could start with the smallpox vaccine then move on to the polio vaccine. Probably should include the measles vaccine in the conversation also.
Those would be a pretty sound foundation.
If 75% of the shareholders voted with their feet and exited Anavex, where did those shares go? The OS certainly didn't decrease.
According to Investor 8% of the institutional investment is in strategic not index funds. Argue that fact with him.
The rest of your post is the usual over the top bashing.
Could be. Overall I don't think there is that coordinated a plan. But then stranger things have happened.
Shorts don't have to collude to have a common goal. They have a common interest. Obviously there is a lot of money at work with a 20,000,000 share short position.
They also must have a plan in case there is a sudden drop of very positive news. We saw in the case of Game Stop that literally several hundred million Dollars was employed to defend the short position before it was overwhelmed.
The market is full of opportunists. That is not a bad thing, it just is. If there are some whales out there the think that Anavex has a good chance of success and the attendant share price rise they might well be watching to see what the shorts do and seize the opportunity if it presents itself.
In general the whales will accept smaller profits for less risk.
As far as the MM's go my sense is most of them that make a market in AVXL are just making market and don't have a big agenda. There are companies that are also MMs that are willing to manipulate. If you keep up with the SEC fines you will see there are clear rule violators that are willing to do illegal things in pursuit of profit.
I did a spreadsheet some time ago that was a swag at how much money the shorts have made while building this short position. I figured it was about $250,000,000. Obviously I had to make many assumptions since hard information is not available. Even so, that provides a clue about how much money is involved.
Sure. There is no way that a 20,000,000 share short position with a value of $100,000,000 or more could have anything to do with the dropping share price.
Oh yeah, every Dollar the share price drops is worth $20,000,000 to the shorts. There is no way they would do things to make that profit, is there?
Nothing to see here. Move a long.
There are segments of the market that are more manipulated than others. In some of those segments retail is at a clear disadvantage. Other segments of the market retail is much less likely to be taken advantage of.
Developmental companies are more subject to manipulation than most companies. Toxic financing is a good example of that. Game Stop was another example of manipulation both by shorts and retail.
Those law firms are paying for those "news releases". Depending on the company they go with a "news release" can cost between $300 and $1000.
https://www.trustradius.com/products/pr-newswire/pricing
https://medicalxpress.com/news/2024-04-mitochondrial-roles-antiviral-immunity-manifestations.html
Possible support for 2-73 in mitochondrial homeostasis restoration.
That has been posted on the board multiple times. https://insidereg.com/preparing-for-an-eu-maa/ https://www.scendea.com/drug-development-in-the-european-union-attaining-accelerated-assessment-aug2020
Um.... you do know that the MAA can't be filed until 7 months after the LOI, right?
Filing the MAA will have nothing to do with the class action case.
I don't understand how you are connecting these things.
So why do you care? If we are such a bunch of losers what is the value of you posting to us about being losers? Do you just like to gloat?
Apparently you don't know much about bad news.
So you discount the 20,000,000 share short position that is valued at roughly $100,000,000. You don't think there are people that are working to protect that very large amount of money?
It is likely that the shorts have made enough off of their shorting over the last year or two that they have zero cash involved in the present short position. That is they could close it out at $8 or more and still be possibly $100,000,000 ahead. Even so they have have a very large exposure at 20,000,000 shares.
You may be right however I am skeptical that any financial organizations would let that amount of potential profit and even larger potential liability just ride and look in on it every once in a while.
Remember that the potential loss on a short position is unlimited. Just ask the Game Stop shorters about that.
That should pay off in the long run and I hope it pays off in the short run.
I'd like to add some at this price myself but alas, I have all the AVXL I need. I am buying a few other stocks with my high risk money.
Why do you think this lawsuit is happening now?
Somehow I must have misinterpreted this.
Does that post have any meaning or is that just your usual deflection?
You may want to read the next sentence which I have copied.
I guess the FDA and the EMU will decide if 2-73 is dead no matter what you believe.
3-71 has been on the corporate drug development chart for a long time.
Fragile X and PD trials are also on the development chart which are 2-73 trials. Doesn't seem so dead to me.
BULLSHIT. NO criminal complaint.
It's a lame civil suit by trolling class action attorneys.
Your misrepresentation is quite straight forward... and OBVIOUS.
Fud much?
Not defending anyone. Pointing out how you misrepresent what he said.
As is your custom you twisted the words that George used. He said that Ern improved. The story did say that he recovered some lost abilities. No one said that he recovered. That is a different situation.
Ern maybe in heaven by now. He was fairly old when that TV story was made. Turns out no one recovers from old age either.
My bad, the if it makes it that far was a paraphrase of the conversation.
I should have just left it at taking the appropriate action.
Which is why he said taking the appropriate actions.
You'll likely stay, maybe independent, but not unbiased.
Rather, as German physicist Max Planck somewhat cynically declared, science advances one funeral at a time. Planck noted “a new scientific truth does not triumph by convincing its opponents and making them see the light, but rather because its opponents die, and a new generation grows up that is familiar with it.”
There are no "alleged crimes". Get your stuff straight. This is a civil matter.
Unless, of course, creating more uncertainty is your goal. Then the misrepresentation is deliberate.
That is how the shorts work to keep the SP down. Create FUD.
You remember how will that last lawsuit worked out for them.
Even so, it was not the case dismissal with prejudice that counted, it was the FUD that was created in the process that worked for the shorts.
Bitch bitch bitch.
Either be patient or sell. Those are your two options.
Well there is a third, bitch bitch bitch.
Patience Grasshopper.
These things happen on their own time schedule.
Had a phone conversation with Anavex IR today.
One question I had was about the class action law suit.
He said the company was not concerned but would take the appropriate actions to defend the suit if it makes that far.
Wow, just wow.